LISINOPRIL, A NEW ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR

被引：2
|
作者：
ARZUBIAGA, C
BECK, NA
机构：
[1] Division of Clinical Pharmacology, Department of Pharmacology, Vanderbilt Univ. School of Medicine, Nashville
来源：
AMERICAN JOURNAL OF THE MEDICAL SCIENCES | 1992年 / 303卷 / 05期
关键词：
ANGIOTENSIN CONVERTING ENZYME INHIBITORS; CONGESTIVE HEART FAILURE; HYPERTENSION; LISINOPRIL;
D O I：
10.1097/00000441-199205000-00015
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：340 / 344
页数：5
相关论文
共 50 条
  • [31] RAPID CONVERSION OF THE NEW ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR RAMIPRIL TO ITS ACTIVE METABOLITE IN RATS
    TABATA, S
    YAMAZAKI, H
    OHTAKE, Y
    HAYASHI, S
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1990, 40-2 (08): : 865 - 867
  • [32] EVALUATION OF A NEW ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR, SPIRAPRIL, IN MILD TO MODERATE ESSENTIAL-HYPERTENSION
    WEBER, MA
    FERRARESI, RW
    POORVIN, D
    JOURNAL OF HYPERTENSION, 1986, 4 : S171 - S173
  • [33] COMBINED TREATMENT OF SEVERE ESSENTIAL-HYPERTENSION WITH THE NEW ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR RAMIPRIL
    PREDEL, HG
    DUSING, R
    BACKER, A
    KIPNOWSKI, J
    KRAMER, HJ
    AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (10): : D143 - D148
  • [34] THE EFFECTS OF TEMOCAPRIL, A NEW ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR, ON THE QUALITY-OF-LIFE IN HYPERTENSIVE PATIENTS
    OGIHARA, T
    NAKAGAWA, M
    ISHIKAWA, H
    MIKAMI, H
    TAKEDA, K
    NONAKA, H
    HIGAKI, J
    SASAKI, S
    KAGOSHIMA, T
    MASUO, K
    MORISHITA, R
    ISHIKAWA, K
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1992, 52 (01): : 81 - 88
  • [35] PERINDOPRIL, A NEW ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR - CLINICAL PHARMACOLOGICAL STUDIES IN HEALTHY-SUBJECTS
    REID, JL
    LEES, KR
    PERRET, L
    CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1987, 9 (2-3) : 361 - 364
  • [36] SYSTEMIC AND RENAL EFFECTS OF A NEW ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR, BENAZEPRIL, IN ESSENTIAL-HYPERTENSION
    VALVO, E
    CASAGRANDE, P
    BEDOGNA, V
    ANTIGA, L
    ALBERTI, D
    ZAMBONI, M
    PEROBELLI, L
    DALSANTO, F
    MASCHIO, G
    JOURNAL OF HYPERTENSION, 1990, 8 (11) : 991 - 995
  • [37] ANTIHYPERTENSIVE, HEMODYNAMIC AND AUTONOMIC PROFILE OF A NEW ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR, SCH 33844 (SPIRAPRIL)
    BAUM, T
    WATKINS, RW
    SYBERTZ, EJ
    AHN, HS
    NELSON, S
    COLEMAN, W
    TEDESCO, R
    PULA, KK
    RIVELLI, M
    SABIN, C
    ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1987, 286 (02): : 230 - 245
  • [38] ANGIOTENSIN-CONVERTING ENZYME DETERMINATION IN PLASMA DURING THERAPY WITH CONVERTING-ENZYME-INHIBITOR - 2 METHODS COMPARED
    GORSKI, TP
    CAMPBELL, DJ
    CLINICAL CHEMISTRY, 1991, 37 (08) : 1390 - 1393
  • [39] MODERATE SODIUM RESTRICTION WITH ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR IN ESSENTIAL-HYPERTENSION
    WALLER, PC
    MCINNES, GT
    BMJ-BRITISH MEDICAL JOURNAL, 1987, 294 (6574): : 769 - 769
  • [40] PHARMACOKINETICS OF THE ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR, PERINDOPRIL, AFTER REPEATED ORAL DOSING
    LEES, KR
    KELMAN, AW
    MEREDITH, P
    REID, JL
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (02) : P233 - P234
12345